Indeed, CD133 aptamer-guided delivery of doxorubicin results in a higher doxorubicin concentration in Huh7 hepatocellular carcinoma stem cells, resulting in a significant decrease in tumorsphere formation [281]. Here, PROM1 is linked to hepatocellular carcinoma.